about
Transcatheter and ablative therapeutic approaches for solid malignancies.Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list.Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.Quantitative proton MR spectroscopy as a biomarker of tumor necrosis in the rabbit VX2 liver tumor.Multidetector CT of hepatocellular carcinoma.Liver and biliary system: evaluation by multidetector CT.Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?Incidental nonneoplastic hypervascular lesions in the noncirrhotic liver: diagnosis with 16-MDCT and 3D CT angiography.Transcatheter arterial chemoembolization: current technique and future promise.Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility studyDrug-eluting particles for interventional pharmacology.Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesionsUnresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model.Chemoembolization for primary and metastatic liver cancer.Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma.Considerations for implantation site of VX2 carcinoma into rabbit liverDoxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancerDistribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy.Evaluation of 70-150-μm doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model.Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver.Percutaneous US-guided implantation of Vx-2 carcinoma into rabbit liver: a comparison with open surgical method.Medium-sized HCC: achieving effective local tumor control with combined chemoebolization and radiofrequency ablation.Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization.Assessment of response of uterine fibroids and myometrium to embolization using diffusion-weighted echoplanar MR imaging.The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.Is CT perfusion ready for liver cancer treatment evaluation?Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization.Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.Three-dimensional rotational angiography: introduction of an adjunctive tool for successful transarterial chemoembolization.Intraarterial Therapy with a New Potent Inhibitor of Tumor Metabolism (3-bromopyruvate): Identification of Therapeutic Dose and Method of Injection in an Animal Model of Liver CancerLow-Dose CT Perfusion of the Liver using Reconstruction of DifferenceFocal Nodular Hyperplasia: Lesion Evaluation Using 16-MDCT and 3D CT AngiographyIs radiofrequency ablation an effective long-term treatment for early-stage hepatocellular carcinoma?Demonstration of Safety and Feasibility of Hydrogel Marking of the Pancreas-Duodenum Interface for Image Guided Radiation Therapy (IGRT) in a Porcine Model: Implications in IGRT for Pancreatic Cancer Patients
P50
Q33277802-308680B9-E85C-4B86-9CE8-A119F0A10664Q33381184-0AF60E9E-4BAC-4C2D-8D83-1CAF63922CA8Q34065055-39E5A2DC-7BEE-44BE-8D5D-CD1D79B2EFE9Q34654186-7EF69D51-07EF-40C9-8628-933F44C8835AQ35101056-1B2661CC-AE2D-449B-AC24-91DB66C01B6EQ36066446-9F924A87-E2B0-441B-BBDD-E8CADC37D758Q36298907-F498162F-F129-4620-813F-DFF405837C81Q36573406-8D846111-D979-4198-9A85-30626E99B9BDQ36575177-3FD49C88-4803-441B-83EA-9DAA0956F77EQ36990903-7D761384-C353-4341-8339-9001105D5E40Q37075313-7E3BFEE1-78B7-497D-8ECE-DFF10FBFCF67Q37197739-41C4E5DD-20B9-4A10-A98F-119249205EC6Q37284591-FA02071D-0854-4F9C-B7EF-2F8584C3C066Q37383964-20A9259F-6B73-4ECF-BAFA-BF893ED87D92Q37407639-DEB34097-4650-41DD-AA76-94415E64A9D3Q37734129-A4BA790C-6280-4979-9D91-CCD2A2F5081EQ37808643-60DB8E3F-A6EC-44CB-8DAD-39AA91DE78D9Q38155510-4C618CC6-EE9A-4B24-AA2C-52B2F4583058Q39863467-17A126A6-5DDF-443A-AE5A-E160A5B78770Q39915670-274DCB95-C2FF-41AF-8925-FE67054EB97FQ39945978-C7C36B7A-5ACA-4049-BAD9-8926108DD81AQ41641204-879A22AB-82B5-4760-9972-48ACB4D5956EQ42560359-D77C73EF-C974-40F5-AA75-D17BDFAD0C9FQ42561905-8C3D70C1-5731-408E-ABA7-1D66BFFAD21EQ43179239-BB403F56-B060-4B37-AE29-DE3741208185Q51066211-2BC45E5C-2B38-422F-B570-0F5CE391BC1AQ51218640-E16F4AAE-4B2E-45BF-A553-A8AB741D729BQ51531138-8E9E4F96-E4D7-4086-9855-D90637663ADAQ51550286-01BAFEB9-0468-4601-9BC9-D74D92E1DAFEQ51813294-E9AFEAB1-B3DE-4FD5-98ED-C5DC4B317105Q53032275-7075FA68-C033-4FFB-A3D6-FF58EC808ABAQ53412904-27A19944-B758-4548-9825-7426B2026C65Q53445890-3A43DDA9-EBDA-400A-A1DE-1CBAD597AA30Q53515665-5D2B89EE-7D84-476F-91F4-E20FF2B532E2Q53570927-74DC33D6-774D-4A2B-AFC2-ABBB9D820206Q60531739-DD85B13D-E0FA-4654-8FD1-A27117EF58B5Q61971023-7ADFDDBC-56DC-45BE-B980-7E17F5F122E0Q61971043-3D9C5FAC-F990-45CE-9825-38C6598E3975Q61971049-778D2495-5EB7-42AA-9CCC-9D8B93F7C842Q88430239-0352FA52-9B84-459E-88ED-F6ABB319AFDC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eleni Liapi
@ast
Eleni Liapi
@en
Eleni Liapi
@es
Eleni Liapi
@nl
Eleni Liapi
@sl
type
label
Eleni Liapi
@ast
Eleni Liapi
@en
Eleni Liapi
@es
Eleni Liapi
@nl
Eleni Liapi
@sl
prefLabel
Eleni Liapi
@ast
Eleni Liapi
@en
Eleni Liapi
@es
Eleni Liapi
@nl
Eleni Liapi
@sl
P106
P1153
8963241600
P21
P31
P496
0000-0001-5864-4448